Clinical Trial Update: High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the MitraClip device to surgical therapy for high- and intermediate-risk degenerative mitral regurgitation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Mitral Regurgitation
• Mitral Valve Insufficiency

Drugs mentioned

• MitraClip

Snippet

Sponsor: University of Zurich | Conditions: Mitral Valve Insufficiency | Phase 4 | Status: TERMINATED